Search Results - "Bernard Haendler"

Refine Results
  1. 1

    Recent Advances in Prostate Cancer Treatment and Drug Discovery by Nevedomskaya, Ekaterina, Baumgart, Simon J, Haendler, Bernard

    “…Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years. The latest approvals include abiraterone acetate,…”
    Get full text
    Journal Article
  2. 2

    From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer by Nevedomskaya, Ekaterina, Haendler, Bernard

    “…Cancer arises following alterations at different cellular levels, including genetic and epigenetic modifications, transcription and translation dysregulation,…”
    Get full text
    Journal Article
  3. 3

    Targeting DNA Damage Response in Prostate and Breast Cancer by Wengner, Antje M, Scholz, Arne, Haendler, Bernard

    “…Steroid hormone signaling induces vast gene expression programs which necessitate the local formation of transcription factories at regulatory regions and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment by Raith, Fabio, O'Donovan, Daniel H, Lemos, Clara, Politz, Oliver, Haendler, Bernard

    “…The reduction in androgen synthesis and the blockade of the androgen receptor (AR) function by chemical castration and AR signaling inhibitors represent the…”
    Get full text
    Journal Article
  6. 6

    Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review by Dziubańska-Kusibab, Paulina J, Nevedomskaya, Ekaterina, Haendler, Bernard

    “…The advent of targeted therapies has led to tremendous improvements in treatment options and their outcomes in the field of oncology. Yet, many cancers…”
    Get full text
    Journal Article
  7. 7

    Exploiting Epigenetic Alterations in Prostate Cancer by Baumgart, Simon J, Haendler, Bernard

    “…Prostate cancer affects an increasing number of men worldwide and is a leading cause of cancer-associated deaths. Beside genetic mutations, many epigenetic…”
    Get full text
    Journal Article
  8. 8

    Dysregulated Transcriptional Control in Prostate Cancer by Baumgart, Simon J, Nevedomskaya, Ekaterina, Haendler, Bernard

    “…Recent advances in whole-genome and transcriptome sequencing of prostate cancer at different stages indicate that a large number of mutations found in tumors…”
    Get full text
    Journal Article
  9. 9

    Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF by Bennett, James, Fedorov, Oleg, Tallant, Cynthia, Monteiro, Octovia, Meier, Julia, Gamble, Vicky, Savitsky, Pavel, Nunez-Alonso, Graciela A, Haendler, Bernard, Rogers, Catherine, Brennan, Paul E, Müller, Susanne, Knapp, Stefan

    Published in Journal of medicinal chemistry (25-02-2016)
    “…TRIM24 is a transcriptional regulator as well as an E3 ubiquitin ligase. It is overexpressed in diverse tumors, and high expression levels have been linked to…”
    Get full text
    Journal Article
  10. 10

    Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation by Baumgart, Simon J., Nevedomskaya, Ekaterina, Lesche, Ralf, Newman, Richard, Mumberg, Dominik, Haendler, Bernard

    Published in Molecular oncology (01-09-2020)
    “…Prostate cancer (PCa) is one of the most frequent tumor types in the male Western population. Early‐stage PCa and late‐stage PCa are dependent on androgen…”
    Get full text
    Journal Article
  11. 11

    Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents by Klingbeil, Olaf, Lesche, Ralf, Gelato, Kathy A, Haendler, Bernard, Lejeune, Pascale

    Published in Cell death & disease (08-09-2016)
    “…Non-small cell lung cancer (NSCLC) has the highest incidence of cancer-related death worldwide and a high medical need for more effective therapies…”
    Get full text
    Journal Article
  12. 12

    Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs by Gelato, Kathy A, Shaikhibrahim, Zaki, Ocker, Matthias, Haendler, Bernard

    Published in Expert opinion on therapeutic targets (02-07-2016)
    “…Histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) were the first epigenetic targets to be successfully addressed for cancer treatment, but more…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model by Suominen, Mari I, Knuuttila, Matias, Schatz, Christoph A, Schlicker, Andreas, Vääräniemi, Jukka, Sjöholm, Birgitta, Alhoniemi, Esa, Haendler, Bernard, Mumberg, Dominik, Käkönen, Sanna-Maria, Scholz, Arne

    “…Radium-223 dichloride and enzalutamide are indicated for metastatic castration-resistant prostate cancer and their combination is currently being investigated…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event? by Douard, Véronique, Brunet, Frédéric, Boussau, Bastien, Ahrens-Fath, Isabelle, Vlaeminck-Guillem, Virginie, Haendler, Bernard, Laudet, Vincent, Guiguen, Yann

    Published in BMC evolutionary biology (18-12-2008)
    “…Based on the observation of an increased number of paralogous genes in teleost fishes compared with other vertebrates and on the conserved synteny between…”
    Get full text
    Journal Article
  17. 17
  18. 18

    BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients by Sugawara, Tatsuo, Lejeune, Pascale, Köhr, Silke, Neuhaus, Roland, Faus, Hortensia, Gelato, Kathy A, Busemann, Matthias, Cleve, Arwed, Lücking, Ulrich, von Nussbaum, Franz, Brands, Michael, Mumberg, Dominik, Jung, Klaus, Stephan, Carsten, Haendler, Bernard

    Published in Oncotarget (02-02-2016)
    “…Androgen receptor (AR) mutations arise in patients developing resistance to hormone deprivation therapies. Here we describe BAY 1024767, a thiohydantoin…”
    Get full text
    Journal Article
  19. 19

    The ubiquitin-specific protease USP10 modulates androgen receptor function by Faus, Hortensia, Meyer, Hellmuth-Alexander, Huber, Martina, Bahr, Inke, Haendler, Bernard

    Published in Molecular and cellular endocrinology (21-12-2005)
    “…The role of the ubiquitin/proteasome system in degrading nuclear hormone receptors and regulating their transcriptional function has emerged in the last few…”
    Get full text
    Journal Article
  20. 20

    Stimulation of N-Terminal Truncated Isoform of Androgen Receptor Stabilizes Human Ether-á-go-go-Related Gene-Encoded Potassium Channel Protein via Activation of Extracellular Signal Regulated Kinase 1/2 by Wu, Zhi-Yuan, Chen, Kun, Haendler, Bernard, McDonald, Thomas V, Bian, Jin-Song

    Published in Endocrinology (Philadelphia) (01-10-2008)
    “…Proarrhythmic drugs induce long QT syndrome more frequently in women than men. The present study was designed to determine whether androgens regulate the…”
    Get full text
    Journal Article